Latest Insider Transactions at Vericel Corp (VCEL)
This section provides a real-time view of insider transactions for Vericel Corp (VCEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vericel Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vericel Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 27
2022
|
Alan L Rubino |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+17.82%
|
-
|
|
Apr 27
2022
|
Kevin F Mclaughlin |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+29.89%
|
-
|
|
Apr 27
2022
|
Steven C Gilman |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+29.89%
|
-
|
|
Apr 27
2022
|
Paul K Wotton |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+8.18%
|
-
|
|
Apr 27
2022
|
Robert L Md Zerbe |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+37.41%
|
-
|
|
Apr 27
2022
|
Lisa Wright |
BUY
Exercise of conversion of derivative security
|
Direct |
2,351
+50.0%
|
-
|
|
Mar 01
2022
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
16,738
-14.97%
|
$686,258
$41.43 P/Share
|
|
Mar 01
2022
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+15.17%
|
$280,000
$14.48 P/Share
|
|
Feb 19
2022
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,875
-2.42%
|
$131,750
$34.9 P/Share
|
|
Feb 19
2022
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,937
+5.28%
|
-
|
|
Feb 19
2022
|
Sean C. Flynn Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
869
-20.14%
|
$29,546
$34.9 P/Share
|
|
Feb 19
2022
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+28.86%
|
-
|
|
Feb 19
2022
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,248
-10.86%
|
$42,432
$34.9 P/Share
|
|
Feb 19
2022
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,812
+19.65%
|
-
|
|
Feb 19
2022
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
730
-1.57%
|
$24,820
$34.9 P/Share
|
|
Feb 19
2022
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+3.62%
|
-
|
|
Feb 11
2022
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,251
-2.1%
|
$113,785
$35.26 P/Share
|
|
Feb 11
2022
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.63%
|
-
|
|
Feb 11
2022
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,564
-15.26%
|
$54,740
$35.26 P/Share
|
|
Feb 11
2022
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+25.46%
|
-
|
|
Feb 11
2022
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
775
-1.7%
|
$27,125
$35.26 P/Share
|
|
Feb 11
2022
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,625
+3.44%
|
-
|
|
Feb 06
2022
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,049
-2.03%
|
$100,617
$33.91 P/Share
|
|
Feb 06
2022
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,937
+4.42%
|
-
|
|
Feb 06
2022
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
931
-12.13%
|
$30,723
$33.91 P/Share
|
|
Feb 06
2022
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+19.63%
|
-
|
|
Feb 06
2022
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
310
-0.7%
|
$10,230
$33.91 P/Share
|
|
Feb 06
2022
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
650
+1.44%
|
-
|
|
Dec 31
2021
|
Joseph Anthony Mara Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,174
-9.18%
|
$45,786
$39.3 P/Share
|
|
Dec 31
2021
|
Joseph Anthony Mara Jr Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+23.83%
|
-
|
|
Dec 22
2021
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,881
-15.24%
|
$595,240
$40.11 P/Share
|
|
Dec 22
2021
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+16.25%
|
$247,000
$13.81 P/Share
|
|
Dec 20
2021
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,000
-2.47%
|
$40,000
$40.0 P/Share
|
|
Dec 20
2021
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+2.41%
|
$10,000
$10.95 P/Share
|
|
Nov 29
2021
|
Steven C Gilman |
SELL
Open market or private sale
|
Direct |
5,000
-58.82%
|
$195,000
$39.17 P/Share
|
|
Nov 29
2021
|
Steven C Gilman |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+37.04%
|
$15,000
$3.74 P/Share
|
|
Oct 27
2021
|
Steven C Gilman |
SELL
Open market or private sale
|
Direct |
5,000
-58.82%
|
$250,000
$50.57 P/Share
|
|
Oct 27
2021
|
Steven C Gilman |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+37.04%
|
$15,000
$3.74 P/Share
|
|
Oct 26
2021
|
Michael Halpin Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-63.71%
|
$500,000
$50.57 P/Share
|
|
Oct 26
2021
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.92%
|
$20,000
$2.65 P/Share
|
|
Sep 30
2021
|
Steven C Gilman |
SELL
Open market or private sale
|
Direct |
5,000
-58.82%
|
$240,000
$48.85 P/Share
|
|
Sep 30
2021
|
Steven C Gilman |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+37.04%
|
$15,000
$3.74 P/Share
|
|
Sep 30
2021
|
Joseph Anthony Mara Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,174
-11.87%
|
$56,352
$48.8 P/Share
|
|
Sep 30
2021
|
Joseph Anthony Mara Jr Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+28.79%
|
-
|
|
Aug 27
2021
|
Sean C. Flynn Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,200
-74.85%
|
$396,000
$55.11 P/Share
|
|
Aug 27
2021
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,200
+42.81%
|
$115,200
$16.25 P/Share
|
|
Aug 16
2021
|
Michael Halpin Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
15,000
-72.73%
|
$720,000
$48.03 P/Share
|
|
Aug 16
2021
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+42.11%
|
$30,000
$2.65 P/Share
|
|
Jul 21
2021
|
Sean C. Flynn Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,800
-53.65%
|
$154,000
$55.01 P/Share
|
|
Jul 21
2021
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,800
+34.92%
|
$44,800
$16.25 P/Share
|